TINF2 mutations in children with severe aplastic anemia.
作者信息
Du Hong-Yan, Mason Philip J, Bessler Monica, Wilson David B
出版信息
Pediatr Blood Cancer. 2009 May;52(5):687. doi: 10.1002/pbc.21903.
Abstract
摘要
相似文献
1
TINF2 mutations in children with severe aplastic anemia.重型再生障碍性贫血患儿的TINF2突变
Pediatr Blood Cancer. 2009 May;52(5):687. doi: 10.1002/pbc.21903.
2
Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.再生障碍性贫血患者携带端粒酶复合物突变时，端粒单链突出端的侵蚀。
Eur J Clin Invest. 2009 Nov;39(11):1025-32. doi: 10.1111/j.1365-2362.2009.02209.x. Epub 2009 Aug 11.
3
Ser245Tyr TINF2 mutation in a long-term survivor after a second myeloablative SCT following late graft failure for Aplastic Anaemia.再生障碍性贫血晚期移植物失败后第二次清髓性异基因造血干细胞移植长期存活者中的Ser245Tyr TINF2突变
Blood Cells Mol Dis. 2015 Aug;55(2):187-8. doi: 10.1016/j.bcmd.2015.01.002. Epub 2015 Jan 17.
4
Identification of TINF2 gene mutations in adult Japanese patients with acquired bone marrow failure syndromes.日本成年获得性骨髓衰竭综合征患者中TINF2基因突变的鉴定
Br J Haematol. 2010 Sep;150(6):725-7. doi: 10.1111/j.1365-2141.2010.08278.x.
5
[Telomere length and gene expression of shelterin in CD3(+) T cell of severe aplastic anemia patients].[重型再生障碍性贫血患者CD3(+) T细胞中端粒长度及保护蛋白的基因表达]
Zhonghua Yi Xue Za Zhi. 2013 May 28;93(20):1533-6.
6
Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.三种新型 TINF2 截断突变导致婴幼儿期严重先天性角化不良
Clin Genet. 2012 May;81(5):470-8. doi: 10.1111/j.1399-0004.2011.01658.x. Epub 2011 Apr 7.
7
Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia.Shelterin 组件 POT1 的表达与严重再生障碍性贫血患者端粒长度缩短和免疫状况有关。
J Immunol Res. 2014;2014:439530. doi: 10.1155/2014/439530. Epub 2014 May 6.
8
Dyskeratosis congenita, stem cells and telomeres.先天性角化不良、干细胞与端粒
Biochim Biophys Acta. 2009 Apr;1792(4):371-9. doi: 10.1016/j.bbadis.2009.01.010. Epub 2009 Feb 7.
9
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.TINF2突变导致端粒极短：对一大群先天性角化不良和相关骨髓衰竭综合征患者的分析。
Blood. 2008 Nov 1;112(9):3594-600. doi: 10.1182/blood-2008-05-153445. Epub 2008 Jul 30.
10
The shelterin complex and hematopoiesis.端粒保护蛋白复合体与造血作用。
J Clin Invest. 2016 May 2;126(5):1621-9. doi: 10.1172/JCI84547.
引用本文的文献
1
Prevalence of pathogenic variants of inborn errors of immunity in critically ill children admitted to the pediatric intensive care unit for sepsis: A Moroccan cohort study.因脓毒症入住儿科重症监护病房的危重症儿童遗传性免疫缺陷病致病变异的患病率：一项摩洛哥队列研究。
Tunis Med. 2025 Jan 5;103(1):93-97. doi: 10.62438/tunismed.v103i1.5182.
2
Telomeres: Dysfunction, Maintenance, Aging and Cancer.端粒：功能障碍、维护、衰老和癌症。
Aging Dis. 2023 Nov 29;15(6):2595-2631. doi: 10.14336/AD.2023.1128.
3
Hematopoietic stem cell transplantation of aplastic anemia by relative with mutations and normal telomere length: A case report.伴有突变且端粒长度正常的亲属对再生障碍性贫血患者进行造血干细胞移植：一例报告
World J Clin Cases. 2023 Oct 16;11(29):7200-7206. doi: 10.12998/wjcc.v11.i29.7200.
4
C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita.C.845G>A：先天性角化不良患者的致病性变异
Balkan J Med Genet. 2022 Jun 5;24(2):89-93. doi: 10.2478/bjmg-2021-0027. eCollection 2021 Nov.
5
Revesz syndrome revisited.重新审视雷维茨综合征。
Orphanet J Rare Dis. 2020 Oct 23;15(1):299. doi: 10.1186/s13023-020-01553-y.
6
Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.移植前短端粒与严重再生障碍性贫血无关供者造血细胞移植后的高死亡风险相关。
Br J Haematol. 2020 Jan;188(2):309-316. doi: 10.1111/bjh.16153. Epub 2019 Aug 19.
7
Loss of RNA-binding protein HuR facilitates cellular senescence through posttranscriptional regulation of TIN2 mRNA.RNA 结合蛋白 HuR 的缺失通过 TIN2 mRNA 的转录后调控促进细胞衰老。
Nucleic Acids Res. 2018 May 4;46(8):4271-4285. doi: 10.1093/nar/gky223.
8
[Clinical and genetic features of dyskeratosis congenital with bone marrow failure in eight patients].8例先天性角化不良伴骨髓衰竭的临床及遗传学特征
Zhonghua Xue Ye Xue Za Zhi. 2016 Mar;37(3):216-20. doi: 10.3760/cma.j.issn.0253-2727.2016.03.008.
9
Molecular basis of telomere dysfunction in human genetic diseases.人类遗传疾病中端粒功能障碍的分子基础。
Nat Struct Mol Biol. 2015 Nov;22(11):867-74. doi: 10.1038/nsmb.3093.
10
Inherited bone marrow failure syndromes in 2012.2012 年遗传性骨髓衰竭综合征。
Int J Hematol. 2013 Jan;97(1):20-9. doi: 10.1007/s12185-012-1249-9. Epub 2012 Dec 28.
本文引用的文献
1
NOLA1 gene mutations in acquired aplastic anemia.获得性再生障碍性贫血中的NOLA1基因突变
Pediatr Blood Cancer. 2009 Mar;52(3):376-8. doi: 10.1002/pbc.21813.
2
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.TINF2突变导致端粒极短：对一大群先天性角化不良和相关骨髓衰竭综合征患者的分析。
Blood. 2008 Nov 1;112(9):3594-600. doi: 10.1182/blood-2008-05-153445. Epub 2008 Jul 30.
3
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.TINF2是端粒保护复合体shelterin的一个组成部分，在先天性角化不良中发生突变。
Am J Hum Genet. 2008 Feb;82(2):501-9. doi: 10.1016/j.ajhg.2007.10.004. Epub 2008 Jan 31.
4
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.再生障碍性贫血或骨髓增生异常综合征患儿中端粒酶RNA突变的低发生率。
J Pediatr Hematol Oncol. 2006 Jul;28(7):450-3. doi: 10.1097/01.mph.0000212952.58597.84.
Zotero 插件